Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 58, member A pseudogene (ENSG00000213386) is classified as a pseudogene, meaning it is a defunct genomic locus that displays sequence similarity to a functional gene (FAM58A), but lacks coding capacity and does not produce a functional protein product. Pseudogenes generally arise by duplication or retrotransposition events and do not serve as targets for drugs, nor are they directly involved in known biological or disease processes[1][6]. This gene is not a protein-coding gene or a recognized therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][6]. There are no known drugs, mechanisms of action, biomarkers, or direct disease roles associated with this pseudogene. Entry is likely inappropriate as a therapeutic or functional genomic target for drug discovery or clinical applications[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 58, member A pseudogene.